Rather, our data are the first, to our knowledge, to show that the activation of AIM2 leads to caspase-4 release in IPF PBMCs, which were not dying cells, but were able to release IL-1α, responsible for TGF β levels. This evidence concerns the gene IL1A and idiopathic pulmonary fibrosis.